The Royal Marsden NHS Foundation Trust

The Royal Marsden NHS Foundation Trust incorporates The Royal Marsden Hospital in London https://www.royalmarsden.nhs.uk/

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site MRI liver facilities
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Oncology services:
    • On-site chemotherapy services
    • On-site External Beam Radiotherapy services
  • Surgical services:
    • On-site hepatobiliary surgical team
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced Nurse
    • Dedicated Specialist Advanced MDT
    • Dedicated Specialist Advanced Outpatient Clinic
    • Complex vascular reconstruction
    • Distal sacrectomy
    • Extended lymphadenectomy
  • Support service facilities:
    • Availability of 24 hour palliative care advice

Data Quality

All Patients: Trust Network National
Number of patients in Audit N/A 1245 29766
Case ascertainment (%) N/A 87 90
Data completeness of:
– Pre-treatment TNM (%) N/A 86 83
– Performance status (%) N/A 97 85
Patients having major resection: Trust Network National
Number of patients in Audit 34 720 16499
ASA grade 1 (%) 0 9 10
ASA grade 2 (%) 56 58 53
ASA grade 3 (%) 29 29 30
ASA grade 4+ (%) 0 2 3
ASA grade not recorded (%) 15 2 4
Data completeness of:
7 Audit items for risk-adjustment (%) 79 68 86

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit N/A 1245 29766
Seen by Clinical Nurse Specialist (%) N/A 94 86
All patients deemed potentially curative Trust Network National
Number of potentially curative patients N/A 324 7226
Undergoing major resection (%) N/A 91 86

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 34 720 16474
Distant metastases (%) 21 6 6
Urgent or emergency surgery (%) 3 13 15
At least 12 lymph nodes excised (%) 100 68 84
Laparoscopic surgery attempted (%) 15 62 72
Risk-adjusted length of stay > 5 days (%) 90 72 62
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit N/A 470 10641
Adjuvant chemotherapy (%) N/A 58 61

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 18 159 3899
Neoadjuvant therapy (%) 86 24 32
Circumferential resection margin: Recorded (%) 83 69 86
Circumferential resection margin: Negative (%) 83 62 79
Rectal volume N/A N/A N/A
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate N/A N/A N/A
APER/Hartmanns (%) N/A N/A N/A

Compare trust outcomes